Phentolamine Mesylate Articles
Ardana's Invicorp launched in Denmark
22 December 2006
Ardana and Senetek sign Invicorp deal
28 June 2004
S-P pulls out of alliance with Zonagen on ED
22 July 2002
Senetek establishes Chinese subsidiary
23 March 2001
Zonagen wins slight reprieve from FDA
8 September 2000
FDA relaxes halt on Invicorp trials
5 July 2000
Zonagen's Vasomax, S-P study completed
20 December 1999
UK suspends Senetek phentolamine studies
19 August 1999
Zonagen crashes as FDA terminates phentolamine studies
12 August 1999
UK MCA recommends approval of Senetek's Invicorp
31 March 1999
Vasomax approved in Brazil
30 March 1999
Schering-Plough Invest In New Belgian Plant
12 November 1998
Senetek & ICN Agreement For AdrenaJect (ReliaJect)
29 October 1998
Solid Growth Forecast For Schering Plough
24 August 1998
First Approval For Senetek's Invicorp
14 July 1998
Senetek Files PLA For INVICORP
9 July 1997
Showing 1-19 of 19 articles
- 1
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
